Prahlad Singh Patel
Tracked across 1 events · 6 articles · First seen Sep 09, 2026 · Last active Sep 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Revvity, Inc. (NYSE: RVTY) announced on September 9, 2026 that it has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specializing in human cell models and preclinical research…
Impact: Prahlad Singh Patel, president and CEO of Revvity, commented that HCD's differentiated human cell models complement Revvity's drug discovery technologies and enable more integrated customer solutions.
Sep 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Prahlad Singh Patel live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard